SK16798A3 - 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof - Google Patents

1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof Download PDF

Info

Publication number
SK16798A3
SK16798A3 SK167-98A SK16798A SK16798A3 SK 16798 A3 SK16798 A3 SK 16798A3 SK 16798 A SK16798 A SK 16798A SK 16798 A3 SK16798 A3 SK 16798A3
Authority
SK
Slovakia
Prior art keywords
formula
derivative
dihydro
compound
methoxy
Prior art date
Application number
SK167-98A
Other languages
English (en)
Slovak (sk)
Inventor
Pascal George
Mireille Sevrin
Philippe Manoury
Michel Peynot
Peretti Daniele De
Jean F Gibert
Arlette Tixidre
David Machnik
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of SK16798A3 publication Critical patent/SK16798A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SK167-98A 1995-08-09 1996-08-01 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof SK16798A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509684A FR2737724B1 (fr) 1995-08-09 1995-08-09 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
PCT/FR1996/001216 WO1997006155A1 (fr) 1995-08-09 1996-08-01 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
SK16798A3 true SK16798A3 (en) 1998-08-05

Family

ID=9481836

Family Applications (1)

Application Number Title Priority Date Filing Date
SK167-98A SK16798A3 (en) 1995-08-09 1996-08-01 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof

Country Status (20)

Country Link
US (1) US5929078A (ko)
EP (1) EP0843670A1 (ko)
JP (1) JP2000501699A (ko)
KR (1) KR19990035954A (ko)
CN (1) CN1199398A (ko)
AR (1) AR003222A1 (ko)
AU (1) AU707372B2 (ko)
BR (1) BR9609977A (ko)
CA (1) CA2228843A1 (ko)
CO (1) CO4750833A1 (ko)
CZ (1) CZ36898A3 (ko)
FR (1) FR2737724B1 (ko)
HU (1) HUP9802546A3 (ko)
IL (1) IL123187A0 (ko)
NO (1) NO980529L (ko)
NZ (1) NZ315363A (ko)
PL (1) PL324966A1 (ko)
SK (1) SK16798A3 (ko)
WO (1) WO1997006155A1 (ko)
ZA (1) ZA966772B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242011B (en) * 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US8106074B2 (en) * 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE358300A (ko) * 1928-04-28
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
NL132357C (ko) * 1966-09-03
DE2037852C3 (de) * 1970-07-30 1980-06-26 Boehringer Sohn Ingelheim Neue Piperazinderivate und Verfahren zu ihrer Herstellung
JP3773255B2 (ja) * 1993-12-28 2006-05-10 ファルマシア・アンド・アップジョン・カンパニー Ｃｎｓおよび心血管系疾患治療用複素環化合物
FR2716193B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
EP0843670A1 (fr) 1998-05-27
IL123187A0 (en) 1998-09-24
BR9609977A (pt) 1999-01-12
AU6705396A (en) 1997-03-05
PL324966A1 (en) 1998-06-22
HUP9802546A3 (en) 1999-10-28
CA2228843A1 (en) 1997-02-20
CO4750833A1 (es) 1999-03-31
ZA966772B (en) 1997-02-19
MX9801057A (es) 1998-05-31
AU707372B2 (en) 1999-07-08
KR19990035954A (ko) 1999-05-25
FR2737724A1 (fr) 1997-02-14
AR003222A1 (es) 1998-07-08
CZ36898A3 (cs) 1998-05-13
JP2000501699A (ja) 2000-02-15
NO980529L (no) 1998-04-14
CN1199398A (zh) 1998-11-18
WO1997006155A1 (fr) 1997-02-20
FR2737724B1 (fr) 1997-09-05
HUP9802546A2 (hu) 1999-02-01
NO980529D0 (no) 1998-02-06
NZ315363A (en) 1998-10-28
US5929078A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
US5935958A (en) Muscarinic antagonists
US8278338B2 (en) Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety
US5932734A (en) N-aminoalkylfluorenecarboxamides
US5010079A (en) Indolone derivatives, their preparation and their application in therapy
US5143916A (en) Naphthylpiperazines useful as 5-ht1a receptor ligands
US5286735A (en) Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics
US5179108A (en) Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application
JP2000086603A (ja) 桂皮酸アミド誘導体および３―フェニルプロピオン酸アミド誘導体
CZ210694A3 (en) Derivatives of piperidine, their use for preparing pharmaceutical preparations, process of their preparation, intermediates for preparing thereof and pharmaceutical compositions based thereon
AU644296B2 (en) 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application
EP1978959B1 (en) Piperidine and piperazine derivatives
US5166156A (en) Naphthyl piperazines useful as 5-HT1A receptor ligands
SK16798A3 (en) 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen- -1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof
US5486527A (en) Anticholinergic agents
EP1776339B1 (en) 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
US4826975A (en) Fused cycloaliphatic aminoalcohols
US5703237A (en) N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
US4902799A (en) Bicyclic alkoxy- and alkylthio-substituted aminoalcohols
AU680327B2 (en) 1-(2-(1H-inden-3-yl)ethyl)-4-(naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics
US5166157A (en) Naphthyl piperazines useful as 5-HT1A receptor ligands
JPH0725851A (ja) ピペリジン類およびピペラジン類
PL143992B1 (en) Process for preparing novel derivatives of phenylacetic acid
PL184412B1 (pl) Nowe pochodne 3,3a,4,5-tetrahydro-1H-oksazolo [3,4-a] chinolin-1-onu, sposób ich wytwarzania i preparat farmaceutyczny
WO1987002035A1 (en) Fused cycloaliphatic aminoalcohols
AU1487299A (en) Biphenyl derivatives as pharmaceuticals